Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDerwent London Regulatory News (DLN)

Share Price Information for Derwent London (DLN)

Share Price is delayed by 15 minutes
Get Live Data
1,843.00    -16.00 (-0.86%)
Bid:
1,843.00
Ask:
1,845.00
Spread: 2.00 (0.109%)
Market Cap: £2.06b
DLN Live PriceLast checked at - London Stock Exchange

Intraday Derwent London Share Chart

Letting Update

18 Oct 2012 08:30

RNS Number : 9517O
Derwent London PLC
18 October 2012
 



18 October 2012

 

Derwent London secures major letting to Ticketmaster at 10-4

 

Pentonville Road, London N1

 

 

 

Derwent London plc ("Derwent London" / "the Group") is pleased to announce that it has let 47,700 sq ft (4,430m2) of office space at 10-4 Pentonville Road, London N1 to Ticketmaster UK.

 

Ticketmaster will occupy the whole of 4 Pentonville Road and the upper five floors of 10 Pentonville Road under a 12-year lease with no breaks. The tenant will pay £1.9 million per annum at this seven floor building, based on £45 per sq ft (£484 per m2) on the top floor and £42.50 per sq ft (£457 per m2) on a typical mid-level floor, with a rent free period of 30 months. There are upward-only rent reviews after five and ten years, with a minimum uplift to £2.0 million after five years.

 

10-4 Pentonville Road is situated in Islington opposite Derwent London's award winning Angel Building. The regeneration of the building has recently been completed, unifying the façade of two former 1980s buildings to create 55,000 sq ft (5,110m2) of offices, which represents more than 20% uplift in floor area.

 

John Burns, Chief Executive Officer of Derwent London, said:

 

"We are pleased to welcome Ticketmaster to our newly regenerated offices at 10-4 Pentonville Road, another leading business taking space in this rapidly improving, vibrant location."

 

-ends-

 

 

For further information please contact:

 

Derwent London 020 7659 3000

 

John Burns, Chief Executive Officer

 

Louise Rich, Head of Investor Relations

 

 

Brunswick Group

 

Elizabeth Adams 020 7404 5959

 

Sheena Shah

 

 

 

Notes to editors

 

Derwent London

 

Derwent London plc is the largest central London focused REIT with an investment portfolio of £2.7bn as at 30 June 2012. The Group is one of London's most innovative office specialist property regenerators and investors and is well known for its design-led philosophy and creative management approach to development.

 

Derwent London's core strategy is to acquire and own a portfolio of central London property that has reversionary rents and significant opportunities to enhance and extract value through refurbishment, regeneration and redevelopment. The Group owns and manages an investment portfolio of 5.3 million sq ft (490,000m2), as at 30 June 2012, of which 96% is located in central London, with a specific focus on the West End and the areas bordering the City of London. Landmark schemes by Derwent London include Angel Building EC1, 8 Fitzroy Street W1, Qube W1, Horseferry House SW1, Johnson Building EC1, Davidson Building WC2 and Tea Building E1.

 

Derwent London came fifth overall in the 2011 Management Today awards for 'Britain's Most Admired Companies' and has also recently won the Estates Gazette Property Company of the Year - Offices award. In 2011, Angel Building was shortlisted for the RIBA Stirling Prize following its RIBA London 2011 award and has also won numerous accolades from organisations such as the British Council for Offices, the British Construction Industry, the American Institute of Architects and New London Architecture.

 

In 2012 the Tea Building won a RIBA regional award and an AJ Retrofit award for the 'Green Tea' refurbishment to improve the environmental performance of the building. Derwent London was also the European listed sector leader for offices in the 2012 GRESB survey.

 

For further information see www.derwentlondon.com or follow us on Twitter at @derwentlondon.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBKODNOBDDAKD
Date   Source Headline
31st May 20244:45 pmRNSTotal Voting Rights
31st May 202410:00 amRNSDirectorate Change
10th May 20241:00 pmRNSResults of 2024 Annual General Meeting
9th May 20247:00 amRNSFirst Quarter Business Update
7th May 20241:00 pmRNSAnnual Bondholders Meeting of LMS Limited
7th May 202410:00 amRNSAdditional Listing
1st May 202411:00 amRNSTotal Voting Rights
25th Apr 202410:00 amRNSSale of Turnmill EC1
9th Apr 20249:30 amRNSNotice of 2024 AGM and 2023 Report & Accounts
28th Mar 20244:45 pmRNSTotal Voting Rights
20th Mar 20245:13 pmRNSBlock listing Interim Review
12th Mar 202410:00 amRNSAdditional Listing
11th Mar 20244:45 pmRNSDirector/PDMR Shareholding
1st Mar 20243:00 pmRNSHolding(s) in Company
29th Feb 20244:45 pmRNSTotal Voting Rights
28th Feb 20247:00 amRNSRESULTS FOR THE YEAR ENDED 31 DECEMBER 2023
31st Jan 20244:45 pmRNSTotal Voting Rights
18th Jan 202411:00 amRNSNotice of Results
9th Jan 202410:10 amRNSHolding(s) in Company
29th Dec 20231:00 pmRNSTotal Voting Rights
1st Dec 20239:45 amRNSHolding(s) in Company
30th Nov 20234:45 pmRNSTotal Voting Rights
17th Nov 20235:35 pmRNSHolding(s) in Company
2nd Nov 20237:00 amRNSDerwent London plc Third Quarter Business Update
31st Oct 20234:45 pmRNSTotal Voting Rights
6th Oct 20239:30 amRNSHolding(s) in Company
5th Oct 20239:45 amRNSHolding(s) in Company
4th Oct 20239:47 amRNSHolding(s) in Company
21st Sep 20233:00 pmRNSDirector/PDMR Shareholding
20th Sep 20234:45 pmRNSBlock listing Interim Review
19th Sep 202310:00 amRNSAdditional Listing
5th Sep 20239:30 amRNSHolding(s) in Company
31st Aug 20234:45 pmRNSTotal Voting Rights
10th Aug 20237:01 amRNSH2 2023 LETTING UPDATE
10th Aug 20237:00 amRNSDerwent London plc - UNAUDITED RESULTS
8th Aug 20233:00 pmRNSHolding(s) in Company
31st Jul 20234:45 pmRNSTotal Voting Rights
30th Jun 20234:45 pmRNSTotal Voting Rights
31st May 20234:45 pmRNSTotal Voting Rights
17th May 20235:30 pmRNSHolding(s) in Company
12th May 20233:00 pmRNSResult of AGM
10th May 20232:30 pmRNSBondholders Meeting
4th May 20237:00 amRNSQ1 2023 Business Update
28th Apr 20234:45 pmRNSTotal Voting Rights
13th Apr 20239:00 amRNS2022 Report & Accounts and Notice of AGM
4th Apr 20233:30 pmRNSDirector/PDMR Shareholding
31st Mar 20234:45 pmRNSTotal Voting Rights
21st Mar 20239:30 amRNSBlock listing Interim Review
15th Mar 20233:08 pmRNSDirector/PDMR Shareholding
9th Mar 202311:30 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.